1 00:00:00,160 --> 00:00:01,920 Speaker 1: So we've got a second lot of findings from a 2 00:00:01,960 --> 00:00:04,400 Speaker 1: massive university drug trends survey and they're a bit of 3 00:00:04,400 --> 00:00:08,240 Speaker 1: a worry. One in four survey responders report using pharmaceuticals 4 00:00:08,240 --> 00:00:11,560 Speaker 1: for recreational use over the past six months. Twenty four 5 00:00:11,600 --> 00:00:15,400 Speaker 1: percent report using MDMA and ketamine and other psychedelics for 6 00:00:15,520 --> 00:00:19,640 Speaker 1: therapeutic purposes. And from the team the massive University in 7 00:00:19,720 --> 00:00:23,000 Speaker 1: New Zealand Drugs research team, I'm joined by doctor Robin 8 00:00:23,560 --> 00:00:27,640 Speaker 1: van Dersand and hello Robin, Hi, how are you very good? 9 00:00:27,640 --> 00:00:30,000 Speaker 1: So to the pharmaceuticals, First, do we have an illegal 10 00:00:30,040 --> 00:00:33,279 Speaker 1: trade in pharmaceuticals and people are sort of selling tramadol 11 00:00:33,320 --> 00:00:33,840 Speaker 1: to each other? 12 00:00:35,840 --> 00:00:38,400 Speaker 2: Potentially a little bit but also potentially a bit more 13 00:00:38,400 --> 00:00:40,839 Speaker 2: boring than that that people are just you know, sharing 14 00:00:40,880 --> 00:00:44,239 Speaker 2: these drugs with one another when in need. But there 15 00:00:44,320 --> 00:00:46,279 Speaker 2: is definitely also a little bit of sale going on. 16 00:00:46,960 --> 00:00:49,280 Speaker 1: So what should we be worried about with the pharmaceuticals. 17 00:00:50,840 --> 00:00:52,680 Speaker 2: A big thing is sort of health and safety. I 18 00:00:52,720 --> 00:00:55,680 Speaker 2: think you know a lot of people who take these 19 00:00:55,720 --> 00:00:58,600 Speaker 2: drugs nor medically might not have gotten the advice of 20 00:00:58,600 --> 00:01:01,360 Speaker 2: their doctor. You know, they might also be mixing these 21 00:01:01,400 --> 00:01:05,280 Speaker 2: drugs together. For example, with alcohol, which is a big 22 00:01:05,360 --> 00:01:09,440 Speaker 2: risk in terms of overdose or poisoning or experiencing harmful effects. 23 00:01:09,840 --> 00:01:12,880 Speaker 2: And also we've got as people are buying these drugs 24 00:01:12,959 --> 00:01:16,480 Speaker 2: illegally via a drug dealer, then we've got this risk 25 00:01:16,560 --> 00:01:18,960 Speaker 2: of them buying counterfeit pharmaceuticals. 26 00:01:19,720 --> 00:01:22,880 Speaker 1: Yes, indeed, and meanwhile to the more traditional drugs, the 27 00:01:23,000 --> 00:01:25,960 Speaker 1: mtumaze et cetera. You're saying, and you've said in your report, 28 00:01:26,000 --> 00:01:28,640 Speaker 1: the world is in the midst of a psychedelic renaissance. 29 00:01:28,680 --> 00:01:29,679 Speaker 1: Now what do you mean by that? 30 00:01:30,920 --> 00:01:33,679 Speaker 2: Well, it sort of means that we've got a kind 31 00:01:33,720 --> 00:01:38,640 Speaker 2: of really renewed interest in psychedelics across different areas of 32 00:01:39,160 --> 00:01:44,840 Speaker 2: society and in the medical sector in terms of healthcare. 33 00:01:44,959 --> 00:01:47,160 Speaker 2: You know, there's a lot of research on the potential 34 00:01:47,200 --> 00:01:51,000 Speaker 2: benefits of psychedelics for a number of mental health benefits 35 00:01:51,000 --> 00:01:54,600 Speaker 2: and therapeutic purposes. You've got a lot of cultural coverage 36 00:01:54,600 --> 00:01:58,680 Speaker 2: of psychedelics, so it's quite a sort of zeitgeist more 37 00:01:58,760 --> 00:02:00,880 Speaker 2: broadly in the culture at them. So that's kind of 38 00:02:00,880 --> 00:02:01,480 Speaker 2: what I mean. 39 00:02:01,360 --> 00:02:03,880 Speaker 1: By that, and one that we need to take great 40 00:02:03,920 --> 00:02:05,800 Speaker 1: care of. And I thank you Robin vanderstanding 41 00:02:06,720 --> 00:02:09,680 Speaker 2: For more from early edition with Ryan Bridge listen live 42 00:02:09,800 --> 00:02:12,800 Speaker 2: to news talks it be from five am weekdays, or 43 00:02:12,880 --> 00:02:14,799 Speaker 2: follow the podcast on iHeartRadio